FDA CRL for Aquestive’s Anaphylm Comes With Clearer Path Forward

Allergy
An allergy is an overreaction of the immune system, in which the body wrongly treats a normally harmless substance as a dangerous invader. (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Immunological

More from Therapy Areas